Acceptance and Commitment Therapy-based Intervention for Parents of a Child With Medical Complexity
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jun 14, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a type of therapy called Acceptance and Commitment Therapy (ACT) to help parents of children with complex medical needs. The goal is to reduce feelings of depression, anxiety, and stress while helping parents become more flexible in how they handle difficult emotions and situations related to their child’s health.
Parents who have a child aged 1 to 18 with complex medical conditions and who can speak and read Chinese are invited to join. Participants need to be willing to take part in face-to-face activities. The study is not for parents who already have a diagnosed mental health condition, are currently involved in other stress-relief programs, or cannot communicate in Cantonese. If eligible, parents can expect to take part in sessions designed to support their mental well-being and learn new ways to cope with the challenges of caring for a medically complex child. This study is not yet recruiting but aims to provide helpful support tailored for these families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • parent of a child with medical complexity aged 1-18
- • able to communicate in Chinese and read Chinese
- • willing to participate in face-to-face activities
- Exclusion Criteria:
- • a reported mental health disorder
- • engaging in other psychosocial educational programs related to stress reduction
- • inability to communicate in Cantonese
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Kowloon, , Hong Kong
Patients applied
Trial Officials
Winsome LAM, PhD
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported